MarginsXMarginsX
Home › Markets › EMMA

Emmaus Life Sciences, Inc. (EMMA)

EMMA is quoted over the counter, not listed on an exchange. Emmaus Life Sciences, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 13, 2026
$0.0230
+53.3% on the day
1-year return
+152.7%
Market cap
$1.6M
Nano cap. From the Nov 13, 2026 close × 70.2M shares (10-Q cover page, Aug 11, 2026)
P/E and P/S
Net loss over the period · 0.1×
On trailing twelve months to June 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerEMMA, quoted over the counter
SEC CIK0000822370
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressTorrance, CA
Incorporated inDE

Warning signs

Cash runway
Cash-flow positive
$2.8M cash at June 30, 2026
Share count, 1 year
+9.9%
2025-08-11 to 2026-08-11 · +30.9% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$15K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"Because the Company's existing cash balance and anticipated cash flows cannot satisfy its current debt and ongoing obligations, combined with the uncommitted nature of the Company's financing plans, there is substantial doubt about the Company's ability to continue as a going concern for 12 months from the date that these condensed consolidated financial statements are issued."
10-Q 2026-08-14
Cash and burn$2.8M cash; operating cash flow $992K a quarter.Report 2026-06-30
Shares outstanding70,188,263 (2026-08-11); 63,865,571 a year earlier; 53,637,554 three years earlier.Cover page 2026-08-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., Costa Mesa, California, United States; changed auditors 1 time in 24 months8-K 4.01 2025-05-06
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $15K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$6.3M$1.3M$1.7M$2.8M$25.0M$15.5M10-Q 2026-08-14
Q1 2026
2026-03-31
$2.0M-$3.3M-$344K$1.1M$26.6M$12.0M10-Q 2026-05-15
Q4 2025
2025-12-31
$3.9M-$2.0M$2.2M$2.1M$27.1M$12.5M10-K 2026-03-31
Q3 2025
2025-09-30
$3.4M-$2.1M$409K$293K$29.1M$11.9M10-Q 2025-11-14
Q2 2025
2025-06-30
$2.8M-$1.1M-$2.9M$886K$29.7M$14.0M10-Q 2026-08-14
Q1 2025
2025-03-31
$2.4M-$2.3M$279K$1.3M$29.0M$16.6M10-Q 2026-05-15
Q4 2024
2024-12-31
$3.3M-$1.7M$343K$1.4M$29.0M$16.7M10-K 2026-03-31
Q3 2024
2024-09-30
$5.5M$1.8M$148K$1.3M$29.3M$20.4M10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52020-03-03
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-08-14
Latest current report8-K2026-08-14
Latest proxyDEF 14A2022-10-31

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier